Related Experiment Video

Updated: Nov 10, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

11.1K

The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and

Mohammad Burhan Uddin1, Zhishan Wang1, Chengfeng Yang2

  • 1Division of Cancer Biology, Department of Medicine, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, 44109, USA.

Molecular Cancer
|April 5, 2021
PubMed

Insights

N6-methyladenosine (m⁶A) RNA methylation regulates cellular processes and is crucial in cancer. Aberrant m⁶A modification impacts oncogenic signaling pathways, offering potential new cancer treatment targets.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Biology

Background:

  • N6-methyladenosine (m⁶A) is the most prevalent internal modification in mammalian messenger RNAs (mRNAs).
  • m⁶A RNA methylation plays critical biological roles by regulating cellular processes.
  • Dysregulation of m⁶A modification is frequently observed in pathological conditions, particularly in cancer.

Purpose of the Study:

  • To review recent studies on oncogenic signaling pathways modulated by m⁶A RNA modification in cancer.
  • To discuss the role of m⁶A regulators in cancer.
  • To provide perspectives for future research and highlight potential therapeutic targets.

Main Methods:

  • Literature review of recent studies on m⁶A RNA modification and oncogenic signaling pathways in cancer.
  • Analysis of the impact of m⁶A on mRNA and noncoding RNA transcripts.
  • Discussion of the regulatory mechanisms and biological consequences of m⁶A dysregulation.

Main Results:

  • m⁶A modification regulates oncogenic signaling pathways at the epitranscriptomic level in various cancers.
  • m⁶A controls RNA fate and metabolism by influencing stability, translation, and subcellular localization.
  • Aberrant expression of m⁶A regulators is linked to cancer development and progression.

Conclusions:

  • m⁶A RNA modification is a key player in cancer, influencing oncogenic signaling pathways.
  • m⁶A regulators represent potential druggable targets for cancer therapy.
  • Further research is needed to fully elucidate the complex roles of m⁶A in cancer and its therapeutic potential.
Keywords:
CarcinogenesisCell transformationEpitranscriptomicsSignal transductionm6A

More Related Videos

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.6K
Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study06:57

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study

Published on: July 7, 2023

1.4K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K